McDonald, from Escanaba, Michigan, told Newsweek that his mom, now 65, was born with a condition called Primary FSGS, which occurs without a known cause. According to the National Kidney ...

Focal segmental glomerulosclerosis (FSGS) is a kidney disease that leads to renal failure, and it affects individuals from different ancestries, the highest prevalence being among African and African ...

FILSPARI could become the first and only FDA-approved treatment for FSGS, a rare kidney condition and a leading cause of kidney failure Additionally, the FDA notified the Company that REMS ...

If approved, FILSPARI could become the first and only FDA-approved treatment for FSGS, a rare kidney condition and a leading cause of kidney failure Additionally, the FDA notified the Company that ...

FSGS is characterized by proteinuria ... Drugs that inhibit the renin-angiotensin system (RAS) can cause kidney injury. Patients whose kidney function may depend in part on the activity of ...

MYH9 deficiency is known to cause kidney disease, and recent work by other groups has ... APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J Am Soc Nephrol. 2011 ...

FILSPARI could become the first and only FDA-approved treatment for FSGS, a rare kidney condition and a leading cause of kidney failure Additionally, the FDA notified the Company that REMS monitoring ...

Drugs that inhibit the renin-angiotensin system (RAS) can cause kidney injury ... statements regarding FILSPARI’s potential in FSGS; and references to estimated sizes of patient populations.

FILSPARI could become the first and only FDA-approved treatment for FSGS, a rare kidney condition and a leading cause of kidney failure Additionally, the FDA notified the Company that REMS ...